Menarini Group Announces Collaboration with VisualDx to Aid in Identifying People Who May Have Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is…
BPDCN is an aggressive hematologic malignancy with a historically poor prognosisVisualDx is…
Sign in to your account